Scleral hypoxia is a target for myopia control
Hao Wu,Wei Chen,Fei Zhao,Qingyi Zhou,Peter S Reinach,Lili Deng,Li Ma,Shumeng Luo,Nethrajeith Srinivasalu,Miaozhen Pan,Yang Hu,Xiaomeng Pei,Jing Sun,Ran Ren,Yinghui Xiong,Zhonglou Zhou,Sen Zhang,Geng Tian,Jianhuo Fang,Lina Zhang,Jidong Lang,Deng Wu,Changqing Zeng,Jia Qu,Xiangtian Zhou,Peter S. Reinach
DOI: https://doi.org/10.1073/pnas.1721443115
IF: 11.1
2018-07-09
Proceedings of the National Academy of Sciences
Abstract:Significance Myopia is the leading cause of visual impairment. Myopic eyes are characterized by scleral extracellular matrix (ECM) remodeling, but the initiators and signaling pathways underlying scleral ECM remodeling in myopia are unknown. In the present study, we found that hypoxia-inducible factor-1α (HIF-1α) signaling promoted myopia through myofibroblast transdifferentiation. Furthermore, antihypoxic treatments prevented the HIF-1α–associated molecular changes, thus suppressing myopia progression. Our findings defined the importance of hypoxia in scleral ECM remodeling and myopia development. The identification of the scleral hypoxia in myopia not only provides a concept for understanding the mechanisms of myopia development but also suggests viable therapeutic approach to control myopia progression in humans.
multidisciplinary sciences